Rajdeep Chowdhury

Dr. Rajdeep Chowdhury


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2018 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
KLK. Lohitesh
K. Lohitesh
RCRajdeep Chowdhury
Rajdeep Chowdhury
SMSudeshna Mukherjee
Sudeshna Mukherjee
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer mortality, accounting for almost 90% of total liver cancer burden. Surgical resection followed by adjuvant and systemic chemotherapy are the most meticulously followed treatment procedures but the complex etiology and high metastatic potential of the disease renders surgical treatment futile in majority of the cases. Another hindrance to the scenario is the acquired resistance to drugs resulting in relapse of the disease. Hence, to provide insights into development of novel therapeutic targets and diagnostic biomarkers, this review focuses on the various molecular mechanisms underlying chemoresistance in HCC. We have provided a comprehensive summary of the various strategies adopted by HCC cells, extending from apoptosis evasion, autophagy activation, drug expulsion to epigenetic transformation as modes of therapy resistance. The role of stem cells in imparting chemoresistance is also discussed. Furthermore, the review also focuses on how this knowledge might be exploited for the development of an effective, prospective therapy against HCC.

11 June 2018 in The Analyst
Verified
Journal Article
Closed access
PDF file
VKVishal Kachwal
Vishal Kachwal
SISai Vamsi Krishna Isukapalli
Sai Vamsi Krishna Isukapalli
LFLeena Fageria
Leena Fageria
JCJagrity Chaudhary
Jagrity Chaudhary
RRRam Kinkar Roy
Ram Kinkar Roy
ILInamur Rahaman Laskar
Inamur Rahaman Laskar
The hidden potential of an AIE-ESIPT active, simple substituted benzothiazole compound has been explored.

17 April 2017 in ACS Omega
Verified
Journal Article
Open access
LFLeena Fageria
Leena Fageria
VPVikram Pareek
Vikram Pareek
RDR. Venkataramana Dilip
R. Venkataramana Dilip
ABArpit Bhargava
Arpit Bhargava
SPSheik Saleem Pasha
Sheik Saleem Pasha
JPJitendra Panwar
Jitendra Panwar
In recent years, the use of silver nanoparticles (AgNPs) in biomedical applications has shown an unprecedented boost along with simultaneous expansion of rapid, high-yielding, and sustainable AgNP synthesis methods that can deliver particles with well-defined characteristics. The present study demonstrates the potential of metal-tolerant soil fungal isolate Penicillium shearii AJP05 for the synthesis of protein-capped AgNPs. The particles were characterized using standard techniques, namely, UV–visible spectroscopy, transmission electron microscopy, X-ray diffraction, and Fourier transform infrared spectroscopy. The anticancer activity of the biosynthesized AgNPs was analyzed in two different cell types with varied origin, for example, epithelial (hepatoma) and mesenchymal (osteosarcoma). The biological NPs (bAgNPs) with fungal-derived outer protein coat were found to be more cytotoxic than bare bAgNPs or chemically synthesized AgNPs (cAgNPs). Elucidation of the molecular mechanism revealed that bAgNPs induce cytotoxicity through elevation of reactive oxygen species (ROS) levels and induction of apoptosis. Upregulation of autophagy and activation of JNK signaling were found to act as a prosurvival strategy upon bAgNP treatment, whereas ERK signaling served as a prodeath signal. Interestingly, inhibition of autophagy increased the production of ROS, resulting in enhanced cell death. Finally, bAgNPs were also found to sensitize cells with acquired resistance to cisplatin, providing valuable insights into the therapeutic potential of bAgNPs. To the best of our knowledge, this is the first study that provides a holistic idea about the molecular mechanisms behind the cytotoxic activity of protein-capped AgNPs synthesized using a metal-tolerant soil fungus.

23 February 2024 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
VDVaibhavi Meghraj Desai
Vaibhavi Meghraj Desai
MCMahima Choudhary
Mahima Choudhary
RCRajdeep Chowdhury
Rajdeep Chowdhury
GSGautam Singhvi
Gautam Singhvi

4 January 2018 in Oncotarget
Verified
Journal Article
Open access
PDF file
SDSubhra Dash
Subhra Dash
PSPrasad M. Sarashetti
Prasad M. Sarashetti
BRBalaji Rajashekar
Balaji Rajashekar
RCRajdeep Chowdhury
Rajdeep Chowdhury
SMSudeshna Mukherjee
Sudeshna Mukherjee
TGF-2-induced EMT is dampened by inhibition of autophagy and TNF- treatment TGF-β2-induced EMT is dampened by inhibition of autophagy and TNF-α treatment

1 February 2021 in Cytokine
Verified
Journal Article
Closed access
SDSubhra Dash
Subhra Dash
ASAnirudha K. Sahu
Anirudha K. Sahu
ASAbhilasha Srivastava
Abhilasha Srivastava
RCRajdeep Chowdhury
Rajdeep Chowdhury
SMSudeshna Mukherjee
Sudeshna Mukherjee